Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net (loss) income	$ 97,573	$ (175,278)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	116,155	99,574
Amortization of Levothyroxine Transition Agreement asset	0	36,393
Unrealized foreign currency loss (gain)	1,251	(3,695)
Amortization of debt issuance costs and discount	4,214	3,218
Gain on sale of international businesses, net	(123)	(6,930)
Intangible asset impairment charges	3,175	79,096
Non-cash restructuring and asset-related charges	0	1,314
Non-cash restructuring and asset-related charges	2,381	8,996
Deferred tax benefit	0	(18,209)
Stock-based compensation	10,202	10,571
Inventory provision	34,708	50,410
Other operating charges and credits, net	4,156	3,155
Changes in assets and liabilities:
Trade accounts receivable, net	75,769	(162,954)
Inventories	(33,182)	(19,658)
Income taxes receivable associated with the CARES Act	(110,069)	0
Prepaid expenses, other current assets and other assets	8,772	28,614
Related party receivables	633	(1,624)
Accounts payable, accrued expenses and other liabilities	15,172	(13,538)
Related party payables	(139)	2,225
Net cash provided by (used in) operating activities	228,267	(87,316)
Cash flows from investing activities:
Purchases of property, plant and equipment	(15,919)	(29,629)
Acquisition of intangible assets	(1,050)	(50,000)
Acquisitions, net of cash acquired	(254,000)	0
Proceeds from sale of international businesses, net of cash sold	0	34,834
Net cash used in investing activities	(270,969)	(44,795)
Cash flows from financing activities:
Proceeds from issuance of debt	180,000	0
Payments of principal on debt, financing leases and other	(17,072)	(13,500)
Payments of deferred financing costs	(4,102)	0
Proceeds from exercise of stock options	158	1,385
Employee payroll tax withholding on restricted stock unit vesting	(557)	(921)
Acquisition of non-controlling interest	0	(3,543)
Tax distribution to non-controlling interest	0	(13,494)
Net cash provided by (used in) financing activities	157,897	(30,939)
Effect of foreign exchange rate on cash	255	1,293
Net increase (decrease) in cash, cash equivalents, and restricted cash	115,450	(161,757)
Cash, cash equivalents, and restricted cash - beginning of period	152,822	218,779
Cash, cash equivalents, and restricted cash - end of period	268,272	57,022
Cash and cash equivalents - end of period	266,143	54,893
Restricted cash - end of period	2,129	2,129
Supplemental disclosure of cash flow information:
Cash paid for interest	68,433	81,103
Cash (paid) received for income taxes, net	(4,518)	8,533
Supplemental disclosure of non-cash investing and financing activity:
Tax distributions to non-controlling interests	1,573	0
Related Party
Cash flows from financing activities:
Payments of principal on financing lease - related party	(530)	(866)
Supplemental disclosure of non-cash investing and financing activity:
Notes payable for acquisitions - related party	$ 36,033	$ 0